Thermo Fisher Scientific (TMO) Change in Accured Expenses (2009 - 2019)

Thermo Fisher Scientific (TMO) has reported Change in Accured Expenses for 11 consecutive years, with $38.0 million the latest figure, recorded in Q4 2019.

• For the quarter ending Q4 2019, Change in Accured Expenses fell 75.8% year-over-year to $38.0 million; the trailing twelve-month figure through Dec 2019 stood at $210.0 million (up 600.0% YoY), and the FY2019 full-year result was $210.0 million, up 600.0% from the prior year.
• Change in Accured Expenses advanced to $38.0 million in Q4 2019 per TMO's latest filing, from -$147.0 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $992.0 million in Q4 2017 and bottomed at -$471.0 million in Q1 2018.
• Historically, Change in Accured Expenses has averaged $80.0 million across 5 years, with a median of $115.2 million in 2015.
• The widest YoY moves for Change in Accured Expenses: up 12019.44% in 2015, down 247.98% in 2015.
• Over 5 years, Change in Accured Expenses stood at $436.3 million in 2015, then decreased by 16.89% to $362.6 million in 2016, then surged by 173.58% to $992.0 million in 2017, then slumped by 84.17% to $157.0 million in 2018, then plunged by 75.8% to $38.0 million in 2019.
• According to Business Quant data, Change in Accured Expenses over the past three periods registered $38.0 million, -$147.0 million, and $549.0 million for Q4 2019, Q3 2019, and Q2 2019 respectively.